Cargando…

Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study

BACKGROUND: Breathomics testing has been considered a promising method for detection and screening for lung cancer. This study aimed to identify breath biomarkers of lung cancer through perioperative dynamic breathomics testing. METHODS: The discovery study was prospectively conducted between Sept 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peiyu, Huang, Qi, Meng, Shushi, Mu, Teng, Liu, Zheng, He, Mengqi, Li, Qingyun, Zhao, Song, Wang, Shaodong, Qiu, Mantang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035731/
https://www.ncbi.nlm.nih.gov/pubmed/35480076
http://dx.doi.org/10.1016/j.eclinm.2022.101384
_version_ 1784693361610850304
author Wang, Peiyu
Huang, Qi
Meng, Shushi
Mu, Teng
Liu, Zheng
He, Mengqi
Li, Qingyun
Zhao, Song
Wang, Shaodong
Qiu, Mantang
author_facet Wang, Peiyu
Huang, Qi
Meng, Shushi
Mu, Teng
Liu, Zheng
He, Mengqi
Li, Qingyun
Zhao, Song
Wang, Shaodong
Qiu, Mantang
author_sort Wang, Peiyu
collection PubMed
description BACKGROUND: Breathomics testing has been considered a promising method for detection and screening for lung cancer. This study aimed to identify breath biomarkers of lung cancer through perioperative dynamic breathomics testing. METHODS: The discovery study was prospectively conducted between Sept 1, 2020 and Dec 31, 2020 in Peking University People's Hospital in China. High-pressure photon ionisation time-of-flight mass spectrometry was used for breathomics testing before surgery and 4 weeks after surgery. 28 volatile organic compounds (VOCs) were selected as candidates based on a literature review. VOCs that changed significantly postoperatively in patients with lung cancer were selected as potential breath biomarkers. An external validation was conducted to evaluate the performance of these VOCs for lung cancer diagnosis. Multivariable logistic regression was used to establish diagnostic models based on selected VOCs. FINDINGS: In the discovery study of 84 patients with lung cancer, perioperative breathomics demonstrated 16 VOCs as lung cancer breath biomarkers. They were classified as aldehydes, hydrocarbons, ketones, carboxylic acids, and furan. In the external validation study including 157 patients with lung cancer and 368 healthy individuals, patients with lung cancer showed elevated spectrum peak intensity of the 16 VOCs after adjusting for age, sex, smoking, and comorbidities. The diagnostic model including 16 VOCs achieved an area under the curve (AUC) of 0.952, sensitivity of 89.2%, specificity of 89.1%, and accuracy of 89.1% in lung cancer diagnosis. The diagnostic model including the top eight VOCs achieved an AUC of 0.931, sensitivity of 86.0%, specificity of 87.2%, and accuracy of 86.9%. INTERPRETATION: Perioperative dynamic breathomics is an effective approach for identifying lung cancer breath biomarkers. 16 lung cancer-related breath VOCs (aldehydes, hydrocarbons, ketones, carboxylic acids, and furan) were identified and validated. Further studies are warranted to investigate the underlying mechanisms of identified VOCs. FUNDING: National Natural Science Foundation of China (82173386) and Peking University People's Hospital Scientific Research Development Founds (RDH2021–07).
format Online
Article
Text
id pubmed-9035731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90357312022-04-26 Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study Wang, Peiyu Huang, Qi Meng, Shushi Mu, Teng Liu, Zheng He, Mengqi Li, Qingyun Zhao, Song Wang, Shaodong Qiu, Mantang EClinicalMedicine Articles BACKGROUND: Breathomics testing has been considered a promising method for detection and screening for lung cancer. This study aimed to identify breath biomarkers of lung cancer through perioperative dynamic breathomics testing. METHODS: The discovery study was prospectively conducted between Sept 1, 2020 and Dec 31, 2020 in Peking University People's Hospital in China. High-pressure photon ionisation time-of-flight mass spectrometry was used for breathomics testing before surgery and 4 weeks after surgery. 28 volatile organic compounds (VOCs) were selected as candidates based on a literature review. VOCs that changed significantly postoperatively in patients with lung cancer were selected as potential breath biomarkers. An external validation was conducted to evaluate the performance of these VOCs for lung cancer diagnosis. Multivariable logistic regression was used to establish diagnostic models based on selected VOCs. FINDINGS: In the discovery study of 84 patients with lung cancer, perioperative breathomics demonstrated 16 VOCs as lung cancer breath biomarkers. They were classified as aldehydes, hydrocarbons, ketones, carboxylic acids, and furan. In the external validation study including 157 patients with lung cancer and 368 healthy individuals, patients with lung cancer showed elevated spectrum peak intensity of the 16 VOCs after adjusting for age, sex, smoking, and comorbidities. The diagnostic model including 16 VOCs achieved an area under the curve (AUC) of 0.952, sensitivity of 89.2%, specificity of 89.1%, and accuracy of 89.1% in lung cancer diagnosis. The diagnostic model including the top eight VOCs achieved an AUC of 0.931, sensitivity of 86.0%, specificity of 87.2%, and accuracy of 86.9%. INTERPRETATION: Perioperative dynamic breathomics is an effective approach for identifying lung cancer breath biomarkers. 16 lung cancer-related breath VOCs (aldehydes, hydrocarbons, ketones, carboxylic acids, and furan) were identified and validated. Further studies are warranted to investigate the underlying mechanisms of identified VOCs. FUNDING: National Natural Science Foundation of China (82173386) and Peking University People's Hospital Scientific Research Development Founds (RDH2021–07). Elsevier 2022-04-16 /pmc/articles/PMC9035731/ /pubmed/35480076 http://dx.doi.org/10.1016/j.eclinm.2022.101384 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Wang, Peiyu
Huang, Qi
Meng, Shushi
Mu, Teng
Liu, Zheng
He, Mengqi
Li, Qingyun
Zhao, Song
Wang, Shaodong
Qiu, Mantang
Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
title Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
title_full Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
title_fullStr Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
title_full_unstemmed Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
title_short Identification of lung cancer breath biomarkers based on perioperative breathomics testing: A prospective observational study
title_sort identification of lung cancer breath biomarkers based on perioperative breathomics testing: a prospective observational study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035731/
https://www.ncbi.nlm.nih.gov/pubmed/35480076
http://dx.doi.org/10.1016/j.eclinm.2022.101384
work_keys_str_mv AT wangpeiyu identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT huangqi identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT mengshushi identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT muteng identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT liuzheng identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT hemengqi identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT liqingyun identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT zhaosong identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT wangshaodong identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy
AT qiumantang identificationoflungcancerbreathbiomarkersbasedonperioperativebreathomicstestingaprospectiveobservationalstudy